AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 JUL 14 - (NewsRx.com & NewsRx.net) -- Transduction of dendritic cells with recombinant adenovirus encoding HCA661 activates autologous cytotoxic T lymphocytes to target hepatoma cells.
According to recent research from China, "Transduction of recombinant adenovirus into dendritic cells (DCs) is a promising new tool for cancer vaccine development. Here, we report that an adenovirus vector carrying hepatocellular carcinoma (HCC) antigen HCA661 and infected into DCs generates T-cell immunity against hepatoma cells. HCA661 is a novel cancer/testis (CT) antigen screened by SEREX from sera of an HCC patient. We constructed a recombinant adenovirus expressing the full-length cDNA of HCA661 gene and then transduced immature DCs, which had been generated with GM-CSF and IL-4 from peripheral blood mononuclear cell of HLA-A2+ healthy donors."
"The resulting adenovirus-transduced DCs differentiated in the presence of monocyte-conditioned medium and poly [I]:poly [C], expressing the surface markers of mature DCs, including CD83, CD80, CD86, and HLA-DR," stated R. C.-F. Chan and collaborators at the Hong Kong University of Science and Technology and Peking University. "After maturation, the transduced DCs transcribed HCA661 mRNA and were able to prime the naive T cells to become cytotoxic T lymphocytes (CTLs). Intracellular flow cytometry and enzyme-linked immunospot assay ...